UA96754C2 - Композиции в виде сухого порошка и системы для вакцинации домашней птицы - Google Patents

Композиции в виде сухого порошка и системы для вакцинации домашней птицы

Info

Publication number
UA96754C2
UA96754C2 UAA200812168A UAA200812168A UA96754C2 UA 96754 C2 UA96754 C2 UA 96754C2 UA A200812168 A UAA200812168 A UA A200812168A UA A200812168 A UAA200812168 A UA A200812168A UA 96754 C2 UA96754 C2 UA 96754C2
Authority
UA
Ukraine
Prior art keywords
dry powder
poultry
powder compositions
systems
vaccination
Prior art date
Application number
UAA200812168A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Жан Поль РЕМОН
Крис ВЕРВАТ
Эви Корбани
Эк Йоханнес Хубертус Хенрикус Ван
Вильхельмус Йоханнес Матернус Ландман
Original Assignee
Университейт Гент
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Университейт Гент filed Critical Университейт Гент
Publication of UA96754C2 publication Critical patent/UA96754C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
UAA200812168A 2006-03-15 2007-03-15 Композиции в виде сухого порошка и системы для вакцинации домашней птицы UA96754C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06005245A EP1834651A1 (en) 2006-03-15 2006-03-15 Compositions and methods for veterinary vaccination

Publications (1)

Publication Number Publication Date
UA96754C2 true UA96754C2 (ru) 2011-12-12

Family

ID=37564170

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812168A UA96754C2 (ru) 2006-03-15 2007-03-15 Композиции в виде сухого порошка и системы для вакцинации домашней птицы

Country Status (14)

Country Link
US (2) US20090041852A1 (enExample)
EP (2) EP1834651A1 (enExample)
JP (1) JP2009529558A (enExample)
CN (1) CN101415437A (enExample)
BR (1) BRPI0708983A2 (enExample)
DK (1) DK1993605T3 (enExample)
ES (1) ES2389864T3 (enExample)
MX (1) MX2008011701A (enExample)
PL (1) PL1993605T3 (enExample)
PT (1) PT1993605E (enExample)
RU (1) RU2450828C2 (enExample)
SI (1) SI1993605T1 (enExample)
UA (1) UA96754C2 (enExample)
WO (1) WO2007104562A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
EP2105129B1 (en) 2008-03-24 2018-01-17 Intervet International B.V. Encapsulated Vaccines for the Oral Vaccination and Boostering of Fish and Other Animals
JP2012504140A (ja) * 2008-09-26 2012-02-16 オーバーン・ユニバーシティ 非複製性ベクターワクチンの粘膜投与による鳥類の免疫処置
CN102481356A (zh) 2009-05-20 2012-05-30 Aeras全球Tb疫苗基金会 稳定的经喷雾干燥的免疫原性的病毒组合物
JP5550277B2 (ja) * 2009-07-23 2014-07-16 長谷川香料株式会社 保存安定性に優れた粉末組成物
RU2592544C2 (ru) * 2009-08-21 2016-07-20 Мериал, Инк. Способ получения рекомбинантного вирусного вектора apmv-8
WO2011041788A2 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Turkey viral hepatitis virus and uses thereof
CN102772799A (zh) * 2012-05-31 2012-11-14 郑州后羿制药有限公司 一种鸭病毒性肝炎、鸭瘟二联卵黄抗体冻干粉及其制备方法
CN103083659B (zh) * 2013-01-18 2015-05-13 北京华夏兴洋生物科技有限公司 新型无油佐剂制备方法及用途
US11510871B2 (en) 2016-09-16 2022-11-29 Leukocare Ag Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
JP7051132B2 (ja) 2016-09-16 2022-04-11 ロイコケア・アクチェンゲゼルシャフト ワクチン接種または遺伝子治療のための効率的なウイルスベクターベースの組成物を得るための新規方法
CN107019707A (zh) * 2017-03-14 2017-08-08 杨凌绿方生物工程有限公司 一种鸡胚成纤维细胞产品冻干工艺方法
TR201718859A2 (tr) * 2017-11-27 2017-12-21 Bilge Kaan Tekelioglu Siğirlarin gangrenli̇ nezlesi̇ i̇çi̇n aşi ve aşinin üreti̇m yöntemi̇
CN109260467B (zh) * 2018-08-17 2021-08-20 山东信得科技股份有限公司 一种预防雏鹅痛风症状的疫苗
EP3698773A1 (en) 2019-02-21 2020-08-26 Università degli Studi di Parma Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination
CN113599513A (zh) * 2020-10-23 2021-11-05 青岛大学 一种适用于咽喉部接种的新型冠状病毒疫苗的制备方法及接种方法
WO2023094818A1 (en) * 2021-11-25 2023-06-01 Orexo Ab Pharmaceutical composition comprising biopharmaceutical drug compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58105310U (ja) * 1982-01-11 1983-07-18 貝原　睦衛 ひよこ用ワクチン点眼装置
JPS5924019U (ja) * 1982-08-05 1984-02-15 イカリ消毒株式会社 動物用ワクチン投与装置
RU2035909C1 (ru) * 1993-06-02 1995-05-27 Виноходов Владимир Олегович Препарат для профилактики и лечения заболеваний птиц
GB9607035D0 (en) * 1996-04-03 1996-06-05 Andaris Ltd Spray-dried microparticles as therapeutic vehicles
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
WO2003087335A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Preservation of bioactive materials by spray drying
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
WO2004058156A2 (en) * 2002-12-17 2004-07-15 Medimmune Vaccines, Inc. High pressure spray-dry of bioactive materials
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
CA2564791A1 (en) * 2004-06-14 2005-12-29 Medimmune Vaccines, Inc. High pressure spray-dry of bioactive materials
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination

Also Published As

Publication number Publication date
RU2450828C2 (ru) 2012-05-20
US20110150940A1 (en) 2011-06-23
MX2008011701A (es) 2008-11-27
WO2007104562A1 (en) 2007-09-20
BRPI0708983A2 (pt) 2011-06-21
SI1993605T1 (sl) 2012-11-30
EP1993605B1 (en) 2012-06-27
US20090041852A1 (en) 2009-02-12
EP1834651A1 (en) 2007-09-19
JP2009529558A (ja) 2009-08-20
CN101415437A (zh) 2009-04-22
PL1993605T3 (pl) 2012-12-31
EP1993605A1 (en) 2008-11-26
RU2008140745A (ru) 2010-04-20
DK1993605T3 (da) 2012-09-10
PT1993605E (pt) 2012-09-17
ES2389864T3 (es) 2012-11-02

Similar Documents

Publication Publication Date Title
UA96754C2 (ru) Композиции в виде сухого порошка и системы для вакцинации домашней птицы
WO2009073508A3 (en) Polysaccharide gel compositions and methods for sustained delivery of drugs
MX2010008898A (es) Polvo fino de poliamida derivado de materiales renovables y proceso para la fabricacion de tal polvo.
PH12017500778A1 (en) COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
NZ600640A (en) Abuse-resistant formulations
MY148405A (en) Immunogenic composition
EP2481402A3 (en) Nanoparticle comprising rapamycin and albumin as anticancer agent
JP2014240439A5 (enExample)
EP4219566A3 (en) Recombinant rsv antigens
EP1786400A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOLOGICAL ACTIVE SUBSTANCES
NZ594024A (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
WO2011019956A3 (en) Pharmaceutical compositions with tetrabenazine
MX2012000035A (es) Antigenos de virus de sincicio respiratorio recombinantes.
JP2009529558A5 (enExample)
EP2395048A3 (en) Polymers compositions including an antioxidant
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
WO2006122223A3 (en) Strategies for delivery of active agents using micelles and particles
MX336777B (es) Peliculas y composiciones que comprenden las mismas.
MX2011003535A (es) Composiciones de virus de herpes bovino-1, vacunas, y metodos.
GB201200858D0 (en) Prebiotic powder composition and uses thereof
MY147485A (en) Improvements in or relating to compositions, articles and methods
TW200727925A (en) Air treatment compositions and devices therefor
WO2011039629A3 (es) Fracción bioactiva de petiveria alliacea, composición farmacéutica que la contiene y combinación con agentes inmunoestimulantes para el tratamiento del cáncer
AU2014226192A8 (en) Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
BRPI0606373A2 (pt) composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma